Early virologic response to pegylated interferon in chronic hepatitis B infection

Niger J Med. 2009 Jul-Sep;18(3):330-1. doi: 10.4314/njm.v18i3.51209.

Abstract

Background: Early virologic response to pegylated interferon in the treatment of chronic hepatitis B infection is not frequently reported.

Method: The case notes of the patients was retrieved and relevant data extracted, literature review was done using Medline.

Result: A report of a case of early virologic response in a 62 year old man with chronic hepatitis B infection, receiving pegylated interferon is presented with a review of the relevant literature. He had HBV DNA level assessed by PCR and histology of liver biopsy specimen.

Conclusion: Clinicians should be on the lookout for early virologic response to pegylated interferon and the eventual outcome of such early response.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use*
  • DNA, Viral / immunology
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / immunology
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / virology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Polyethylene Glycols / therapeutic use*
  • Polymerase Chain Reaction
  • Recombinant Proteins
  • Treatment Outcome

Substances

  • Antiviral Agents
  • DNA, Viral
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a